AI Article Synopsis

  • Paragangliomas are rare benign tumors that typically develop from chemoreceptor tissue and are usually located in areas like the carotid artery and aortic arch, with liver metastasis being very uncommon.
  • A case of a 39-year-old woman is presented, who had a retroperitoneal paraganglioma removed 12 years ago but later developed a hepatic mass mistakenly treated as hepatocellular carcinoma, which was later identified as metastatic paraganglioma.
  • Despite undergoing transarterial chemoembolization (TACE) without significant response, the liver metastasis remained stable over 7 years, highlighting the need for ongoing monitoring and consideration of treatments for symptom management and quality of life.

Article Abstract

Background: Paragangliomas, also known as chemodectomas, are rare tumors arise from chemoreceptor tissue, and most commonly locate at the bifurcation of the common carotid, the jugular foramen, aortic arch, and retroperitoneum. Paragangliomas generally are considered to be benign tumors, and rarely produce local or distant metastases. Metastasis to liver is extremely rare.

Case Presentation: We report the case of a 39-year-old woman, who had undergone resection of a retroperitoneal paraganglioma at her local hospital for 12 years. She was referred to our hospital for further evaluation of a hepatic mass, which was misdignosed as hepatocellular carcinoma (HCC) and was treated by transarterial chemoembolization (TACE) in the local hospital 6 years ago. At admission, CT scan revealed a huge hypervascular mass with many feeding arteries, almost the same size as 5 years ago. Ultrasound-guided biopsy of the liver tumor was performed and immunohistochemical examination confirmed the diagnosis of hepatic metastatic paraganglioma. Though liver metastasis failed to achieve complete response or partial response to TACE treatment, it remained stable without progression during the 7-year follow-up.

Conclusion: Paragangliomas are slow growing tumors and metastasis may develop decades after resection of the primary lesion. Long-term follow-up is necessary, and curative or palliative treatment should be considered to control symptoms, improve life quality, reduce complications and prolong survival.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688228PMC
http://dx.doi.org/10.1186/s12876-019-1061-6DOI Listing

Publication Analysis

Top Keywords

hepatic metastatic
8
metastatic paraganglioma
8
retroperitoneal paraganglioma
8
local hospital
8
paraganglioma
4
paraganglioma 12 years
4
12 years retroperitoneal
4
paraganglioma resection
4
resection case
4
case report
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!